Search Results
Results found for "cAM SINH LU"
- Dr. Josephine (Pina) Cardarelli | Dr. GPCR Ecosystem
project, licensed to AstraZeneca (Saphnelo™ Anifrolumab) that has just received FDA approval for systemic lupus
- Dr. Nariman Balenga | Dr. GPCR Ecosystem
Druey at NIAID/NIH, where I characterized the role of RGS4 and RGS5 in airway hyperresponsiveness and lung fascinated by the multitude of processes that are regulated/dysregulated by GPCRs and RGS proteins in the lungs
- Masha Niv: Bitter Taste Receptors and the Drug Discovery Blind Spot | Dr. GPCR Ecosystem
consequences: drugs targeting other receptors may be inadvertently activating bitter taste GPCRs in the lung
- Paul Insel: Rethinking COVID-19 Pathobiology Through GPCR Signaling | Dr. GPCR Ecosystem
The lung's beta-2 story has been sitting in plain sight for fifty years.
- Dr. Neil Grimsey | Dr. GPCR Ecosystem
p38 signaling responses we are studying how atypical p38 controls the onset and pathogenesis of acute lung
- Bryan Roth: Inside the DARPA Bet on a Non-Psychedelic Psychedelic | Dr. GPCR Ecosystem
receptors 06:30 When the field debated whether opioid receptors were even proteins 11:31 The "dumb luck
- Dr. Caron Tribute Part 1 | Dr. GPCR Ecosystem
Frederik Leeb-Lundberg (1984) Dr. Robert Lefkowitz (1973) Dr. Lee Limbird (1973) Dr.
- Graciela Piñeyro: Partial Agonism, Receptor Recycling, and the Limits of Bias | Dr. GPCR Ecosystem
This interest in research and pharmacology took Graciela to Canada where she stayed ever since she arrived
- Paul Insel: Unbiased Discovery and the GPCRs We've Been Missing | Dr. GPCR Ecosystem
From that point on, Paul was hooked and has since studied receptor function in human physiology, receptor
- Debbie Hay: Class B GPCRs, RAMPs, and the Migraine Pharmacology Gap | Dr. GPCR Ecosystem
For Hay, who has studied RAMPs since they were first described and when working on them was a high-risk
- Chris Tate: Thermostabilizing GPCRs for Structural Biology | Dr. GPCR Ecosystem
He co-founded Heptares (now Sosei Heptares) in 2007, a company that has since produced over 250 GPCR
- GPCR Webinars | Dr. GPCR Ecosystem
David Hodson Topics Covered: LUXendin probes for GLP-1R labeling across imaging modalities daLUXendin
- Celtarys Research | Dr. GPCR Ecosystem
examine the assay principle, validation strategy, and performance across reference antagonists and agonis LucĂa degenerative, metabolic, immunological… around a third of the drugs in clinical use are GPCR ligands LucĂa
- Revvity | Dr. GPCR Ecosystem
Arrestin Recruitment Detect β-arrestin recruitment with TR-FRET and luminescence assays tailored for
- Pod-Be Our Guest - Public | Dr. GPCR Ecosystem
Inspire young scientists to work on GPCRs It’s been a privilege to chat with so many GPCR scientists since
- Michel Bouvier: BRET, Biased Agonism, and the Tools That Changed GPCR Pharmacology | Dr. GPCR Ecosystem
Since 2001, he holds the Canada Research Chair in Signal Transduction and Molecular Pharmacology.
- Fresh, Fresh, GPCR News ❇ Feb 17 - 23, 2025 | Dr. GPCR Ecosystem
Lamichhane Discovery of CCR8 Antagonist IDOR-1136-5177 for the Treatment of Cancer Stefan Diethelm , Luboš
- Antony Boucard: Adhesion GPCRs and the Molecular Code of Synapse Formation | Dr. GPCR Ecosystem
outcomes shaped as much by openness as by design — has followed him through every phase of his career since

















